Prognostic value of preoperative CA199 in advanced colorectal cancer patients with normal carcinoembryonic antigen level
10.3969/j.issn.1000-8179.20150777
- VernacularTitle:CA199在判断CEA正常的中晚期结直肠癌患者预后中的价值
- Author:
Lei CHEN
;
Beihai JIANG
;
Jiabo DI
;
Chenghai ZHANG
;
Zaozao WANG
;
Nan ZHANG
;
Jiadi XING
;
Ming CUI
;
Hong YANG
;
Zhendan YAO
;
Xiangqian SU
- Publication Type:Journal Article
- Keywords:
CEA;
CA199;
colorectal cancer;
prognosis;
overall survival;
disease-free survival
- From:
Chinese Journal of Clinical Oncology
2015;(15):743-750
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate whether increased levels of preoperative carcinoembryonic antigen (CEA) and CA199 were associated with the mortality of patients with advanced colorectal cancer and to determine whether CA199 can be used to discriminate patients with normal preoperative CEA level from good to poor prognosis. Methods:A total of 314 patients with advanced colorectal cancer cases who underwent primary tumor resection were collected from 2014 to 2016 at Peking University Cancer Hospital and Institute. Preoperative CEA and CA199 serum levels were examined using electrochemiluminescence immunoassay. The association of CEA and CA199 with clinicopathologic features and their possible prognostic values were analyzed. Results:In the tested patients, 5.4%of whom had increased CA199 level but not up-regulated CEA level, whereas 28.3%only had increased CEA level, and 21.3%had both CEA and CA199 levels increased. Kaplan-Meier survival curves indicated that patients with elevated preoperative CEA level had worse disease-free survival (DFS) and overall survival (OS) than those with normal CEA (P<0.001 and P<0.001, respectively). Meanwhile, patients with elevated CA199 level had worse DFS and OS than those with normal CA199 (P<0.001 and P<0.001, respectively). Preoperative CA199 level could be used in discriminating patients with normal CEA from good to poor prognosis (P=0.012). Multivariate analysis revealed that elevated CA199 level was an independent prognostic factor for OS in patients with advanced colorectal cancer (HR=2.025, 95%CI=1.331-3.082, P=0.001). Conclusion:Combined detection of preoperative CEA and CA199 can be used in evaluating the prognosis of patients with advanced colorectal cancer. Preoperative serum CA199 level can be used in evaluating the prognosis of patients with colorectal cancer without an increase in CEA level. Patients with increased CA199 level had worse 5-year survival than those with increased CEA level.
